
(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Best Getaway destination: Ocean side, Mountain, or City - 2
A Manual for Well known Western television Series - 3
IDF bans Android phones for senior officers, iPhones now mandatory, Army Radio reports - 4
Grasping the Commencement of Criminal Cases: An Extensive Outline - 5
The Hybrid Volkswagen ID. ERA 9X Will Become the Brand’s New Flagship in China
Warnings rise for U.S. as severe flu strain causes outbreaks in Canada, U.K.
$30K Disability Scam Implodes After Surf Trip in Mexico
Saudi Arabia says it intercepted 7 missiles, debris falls near energy facilities
The most effective method to Begin Your Excursion in Gold Venture
5 VIP Voice Exhibitions in Energized Movies
Students were skipping my astrophysics class to play video games – so I turned the class itself into a video game
UN chief calls on Yemen's Houthi rebels to free all UN detainees
Colombia's military rescues 6 siblings who hid in the rainforest to escape from a rebel group
Winona Ryder didn't take the 'Stranger Things' plot lightly. How 'otherworldly' grief and a kidnapping in her hometown informed her character.












